Eusolex 6300 UVB Filter Deserves Sunscreen Monograph Status, Merck Says
This article was originally published in The Tan Sheet
Merck KgaA asks FDA to reopen the OTC drug sunscreen monograph to include additional information on its UVB filter Eusolex 6300, or 3-(4-methyl-benzylidene) camphor, in an April 12 supplement to its 1980 petition to the agency.
You may also be interested in...
Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC